echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Nature Aging: Zeng Jianxiong et al. of the Chinese Academy of Sciences discovered the key mechanism of innate immune cGAS-STING pathway activation and inhibition of the pathogenesis of Alzheimer's disease

    Nature Aging: Zeng Jianxiong et al. of the Chinese Academy of Sciences discovered the key mechanism of innate immune cGAS-STING pathway activation and inhibition of the pathogenesis of Alzheimer's disease

    • Last Update: 2023-02-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    iNature


    CICL GMP SATASE (CGAS) DETECTS MICROBIAL AND HOST-DERIVED DOUBLE-STRANDED DNA IN THE CYTOPLASM TO TRIGGER CELLULAR INNATE IMMUNE RESPONSES
    IN A STIMULATOR OF INTERFERON GENES (STING)-DEPENDENT MANNER.
    However, whether the cGAS-STING pathway in innate immunity contributes to Alzheimer's disease (AD) is unclear
    .

    On January 9, 2023, Zeng Jianxiong's research group at the Kunming Institute of Zoology, Chinese Academy of Sciences, and Zhen Zhao's research group at the University of Southern California, published an online report entitled "Activation of innate immune cGAS-STING pathway contributes to Alzheimer's pathogenesis in 5× in the journal Nature Aging FAD mice" research paper
    .
    The study detected cytoplasmic binding of cGAS to dsDNA and subsequent activation
    of the cGAS-sting pathway in the brains of human AD and aged mice.
    In the 5′FAD mouse model, both hereditary Cgas deficiency and STING inhibitors alleviated the pathogenesis of AD, which may be partly due to the inhibition
    of neurotoxic A1 astrocytes.
    These findings are consistent with
    the idea that innate immunity plays a key role in the pathogenesis and progression of AD.

    Together, this study has identified key molecular links between innate immunity and AD and suggests that therapeutic targeting of cGAS-STING pathway activity may effectively interfere with the progression of
    AD.

    Detecting foreign DNA is a key process in the immunity of
    many organisms.
    In mammalian cells, this process is primarily mediated by the circulating GMP-AMP synthase (cGAS)-interferon gene stimulating factor (STING) pathway, which is a mechanistic coupling
    between DNA sensing and triggering of effective innate immune defense programs.
    In this pathway, cGAS binds to double-stranded DNA (dsDNA), allosteric activates its catalytic activity, and produces 2'3' loop GMP-AMP (2'3'-cGAMP), a second messenger molecule, and a potent agonist
    of STING2-6.
    ACTIVATED STING RECRUITS TANK-BINDING KINASE 1 (TBK1), WHICH CAN PHOSPHORYLATE STING AND THE TRANSCRIPTION FACTOR INTERFERON REGULATOR 3 (IRF3).

    Phosphorylation of IRF3 leads to its dimerization and translocation into the nucleus, where phosphorylated IRF3 and nuclear factor κB (NF-κB), the latter is a transcription factor that is also activated by STING, working together to initiate the expression of type I interferons (IFNs) and inflammatory factors, triggering a broad immune response
    .
    However, the cGAS-sting pathway plays a biological role beyond antimicrobial defense, as cGAS senses and binds dsDNA
    in a sequence-independent way.
    cGAS can be activated
    by cytoplasmic auto-DNA derived from genomic or mitochondrial DNA (mtDNA).
    There is growing evidence that the cGAS-STING pathway plays an increasingly important role in a variety of physiological and pathological processes, including host defense against microbial infection, anti-tumor immunity, cellular senescence, autophagy, autoimmune, and inflammatory diseases
    .
    Recent studies have shown that the cGAS-STING pathway is involved in neurological disorders such as ischemic brain injury, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis
    .
    In these diseases, acute or chronic neuroinflammatory responses induced by the cGAS-STING pathway contribute to the pathological progression
    of the disease.
    In particular, in tau pathology in Alzheimer's disease (AD), the most common neurodegenerative disease, the microglial cGAS-STING pathway may play an important role
    in brain inflammation.
    However, whether and how the innate immune cGAS-STING pathway is involved in the development and progression of amyloid pathology in AD is unclear
    .
    AD is characterized by the accumulation of amyloid β (Aβ) in plaques, overphosphorylated tau aggregation in nerve fiber tangles, and neuroinflammation, which together lead to neurodegeneration and cognitive decline
    .
    Neurodegenerative proteins such as Aβ can cause oxidative damage to mitochondrial DNA and DNA double-strand breaks (dsb) in neuronal cultures, which may increase cytoplasmic dsDNA28 levels
    .
    cGAS and STING are mainly expressed in microglia, resident immune cells of the central nervous system (CNS), so
    the type I IFNs and inflammatory responses induced by the cGAS-STING pathway are potent in microglia and weaker
    in neurons and astrocytes under viral infection conditions.
    In this study, the researchers demonstrated detectable binding of cGAS double-stranded DNA and activation of the microglial cGAS-STING pathway in the cytoplasm in the brains of human AD and aged mice
    .
    Cgas−/−; 5×FAD mice are largely protected from cognitive impairment, amyloid-β pathology, neuroinflammation, and other AD-related sequelae
    .
    In addition, microglia lack of Cgas inhibits the neurotoxic A1 astrocyte phenotype, thereby mitigating amyloid oligo-β peptide-induced neurotoxicity
    .
    Finally, the administration of STING inhibitor H-151 effectively inhibited the activation of the cGAS-STING pathway in 5×FAD mice and improved the pathogenesis
    of AD.
    Administration of STING inhibitor H-151 improves Aβ pathology and neuroinflammation in mice 5 ́FAD (Image from Nature Aging) Overall, this study revealed the unknown role of the cGAS-STING pathway in AD amyloid pathology and cognitive impairment, identifying the cGAS-STING pathway as a key molecular link between innate immunity and AD and reveal the complex interactions
    between microglia, astrocytes, and neurons in the neuroinflammatory microenvironment.
    Future research is necessary to further explore how neurodegenerative changes are carefully modulated by innate or adaptive immunity, and whether these harmful effects on neuronal function can be partially improved or even reversed
    .

    Information:
    style="margin-right: auto;margin-left: auto;outline: 0px;width: 30px;display: inline-block;">

    END

    The content is [iNature]

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.